SCHEMBL9818973

SCHEMBL9818973

O=C(NC1(C(=O)O)C[C@@H](Cc2ccccc2)Oc2ccc(Br)cc21)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40
AKR1B1 P15121 2/20 0.40
BACE1 P56817 4/20 0.38
KCNH2 Q12809 1/20 0.38
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HPGD P15428 1/20 0.35
FAAH O00519 2/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
TP53 P04637 2/20 0.34
GLA P06280 1/20 0.34
MAPT P10636 2/20 0.33
CNR2 P34972 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9818970 1.00 MAPK1 (0.40) MAPK1CYP2C19AKR1B1BACE1KCNH2
SCHEMBL27276603 0.85 AKR1B1 (0.41) CYP2C19AKR1B1BACE1KCNH2SLC6A2
SCHEMBL10487420 0.75 AKR1B1 (0.66) AKR1B1
SCHEMBL9818906 0.75 AKR1B1 (0.66) AKR1B1
SCHEMBL9818912 0.75 AKR1B1 (0.66) AKR1B1
SCHEMBL1979448 0.72 AKR1B1 (0.45) AKR1B1BACE1KCNH2MAPT
SCHEMBL10487558 0.67 AKR1B1 (0.50) MAPK1CYP2C19AKR1B1RAB9ANPC1
SCHEMBL10487556 0.67 AKR1B1 (0.50) MAPK1CYP2C19AKR1B1RAB9ANPC1
SCHEMBL10368729 0.65 HRH3 (0.41) BACE1KCNH2RAB9ANPC1SMN1; SMN2
SCHEMBL10487436 0.64 AKR1B1 (0.54) AKR1B1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0230379-B1 CHROMAN- AND THIOCHROMAN-4-ACETIC ACIDS USEFUL IN THE TREATMENT OF DIABETIC COMPLICATIONS PFIZER INC. (US) 1991-04-03 EP disclosed
US-4853410-A Hydroxyacetic acid derivatives for the treatment of diabetic complications PFIZER INC. (US) 1989-08-01 US disclosed
WO-1987004344-A1 HYDROXYACETIC ACID DERIVATIVES FOR THE TREATMENT OF DIABETIC COMPLICATIONS PFIZER INC. (US) 1987-07-30 WO disclosed
EP-0230379-A2 Chroman- and thiochroman-4-acetic acids useful in the treatment of diabetic complications PFIZER INC. (US) 1987-07-29 EP disclosed